Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
20-4
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Issue 20-4
News Flashes
advertisement
News Flashes
IGR 20-4
The pandemic has created the opportunity for our specialty to advance new and innovative methods of health care delivery and accelerate research into making glaucoma care safer, more convenient, and more accessible to our patients than ever before
If remote perimetry/tonometry are ever going to become viable alternatives to in-clinic testing, now would be the time
Performing in vivo TM imaging with segmental information (such as from aqueous angiography) could yield additional insight into TM biology and potentially lead to novel outflow-based glaucoma therapies
The severity of glaucomatous optic nerve damage was not related with the degree of OSA
Slowing of glaucoma progression after IOP lowering treatment may be, at least partly, attributed, to the improved perfusion to the optic nerve
A more pronounced IOP reduction may be required in eyes with LC defects, because these eyes may be more susceptible to glaucoma progression
SLT is unlikely to have adequate treatment effect in patients requiring very low intraocular pressures
Phacoemulsification alone is able to decrease the IOP, reduce the extent of PAS and increase aqueous outflow facility
Optimal time for phacoemulsification to reduce the risk of trabeculectomy failure has been controversial
Cataract surgery within one year after trabeculectomy dramatically affect the success rate and should be avoided unless it is necessary
With the outcomes from LiGHT continuing to demonstrate the favorability of SLT, we are due an evidence-based paradigm shift
Lower parapapillary choroidal vessel density (VD) with B-zone parapapillary atrophy (PPA) at baseline is associated with future visual field progression
Advise against performing bench press to muscular failure with heavy loads in patients with glaucoma or risk factors
Isometric training with heavy loads (triggering Valsalva) is associated with IOP increase
Corneal deflection amplitude is an interesting corneal behavior that may be related to glaucoma progression
A possible beneficial effect on IOP in older adults which could protect against glaucoma
This device and study represent an important step toward the holy grail of accurate and continuous IOP monitoring in eyes with glaucoma
Bleb grading systems are fraught with error by nature of their subjectivity
This study shows that DL can also be used to directly model structure-function relationships and identify eyes with likely functional loss from OCT imaging
Examining features of imaging, other than thickness, e.g., texture or voxel intensity, may provide additional value for glaucoma detection and monitoring
Prior to the landmark Zhongshan Angle Closure Prevention (ZAP) trial, the benefit of treating PACS eyes with LPI was unclear
Authors estimated that 44 and 126 LPI would need to be performed to prevent one case of PAC and PACG, respectively
The LiGHT trial supports the use of a second SLT when an initial SLT is not enough to reach the target IOP or when the IOP further goes up
GRS-based genetic risk estimates may aid in early disease detection, thereby allowing for timely initiation of preventive treatment and management strategies
This paper demonstrates the molecular complexity of glaucoma and questions this division in glaucoma based on arbitrary measurements of intraocular pressure (IOP)
One can now safely say MYOC is no longer only a gene associated with only high IOP
The optical clarity presents an advantage over a number of murine mode, making this work a significant contribution to pre-clinical glaucoma modelling
Differing patient characteristics may have directed the surgeon toward insertion of the tube into the AC or PP, and this is a potential source of selection bias
The work is not yet able to conclude whether a specific strain pattern for any given ethnicity would be responsible for the development and progression and glaucoma
In-vivo ONH strains are thus more representative of what ONH cells directly experience
Moving forward, it is becoming clearer that glaucoma subjects would benefit from a clinical test to assess the robustness of their ONHs
Issue
20-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement
